Quick Facts at a Glance
- Recall Date
- December 31, 2025
- Hazard Level
- HIGH
- Brands
- LEVOTHYROXINE SODIUM, Alvogen, Inc.
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- LEVOTHYROXINE SODIUM, Alvogen, Inc.
- Product type
- Levothyroxine Sodium Tablets
- Model numbers
- Lot # MHA21825, Exp Date: December 31, 2027
- UPC codes
- 47781-640, 47781-643, 47781-646, 47781-649, 47781-651, 47781-654, 47781-657, 47781-659 +12 more
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
December 31, 2025
Reported by FDA DRUG
January 21, 2026
RecallRadar source check
January 28, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Alvogen, Inc or your healthcare provider for guidance. Notification method: Letter
About This Product
Levothyroxine Sodium Tablets are commonly prescribed to treat thyroid hormone deficiency. They help regulate metabolism and maintain energy levels in patients with hypothyroidism.
Why This Is Dangerous
This recall stems from a product mix-up where a bottle containing 88 mcg tablets was mistakenly labeled as containing 150 mcg tablets. Taking the incorrect dosage can significantly impact patient health.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
The recall poses a significant risk to patients relying on the specific dosage of Levothyroxine Sodium. Consumers should act quickly to address the recall.
Practical Guidance
How to identify if yours is affected
- Check the lot number on your Levothyroxine Sodium Tablets bottle.
- Verify if it matches MHA21825 to determine if it is affected by the recall.
- Consult your healthcare provider if you are unsure about the lot number.
Where to find product info
The lot number can typically be found on the label or bottom of the bottle.
What timeline to expect
Expect a refund or replacement processing time of approximately 4-6 weeks.
If the manufacturer is unresponsive
- Document all correspondence with the company.
- Consider contacting the FDA if you receive no response from Alvogen.
How to prevent similar issues
- Always verify the dosage and expiration date before taking medication.
- Discuss any concerns about your prescription with your healthcare provider.
Documentation advice
Keep records of all communications with Alvogen, including dates and details of your inquiries.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Reported Incidents
Only one incident of product mix-up has been reported, affecting a single bottle. There are no additional reported injuries or health complications at this time.
Key Facts
- Recall Date: January 21, 2026
- Affected Lot: MHA21825
- Expiration Date: December 31, 2027
- Dosage Confusion: 88 mcg vs 150 mcg
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
